We are live on ! Find out more
NLSPW

NLS Pharmaceutics Warrant
NLSPW

Delisted

NLSPW was delisted on the 30th of October, 2025.

Back to rankings

0 hedge funds and large institutions have $0 invested in NLS Pharmaceutics Warrant in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $1.77K → $0 (-$1.77K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
–
Holders Change
-3
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CS
Clear Street
New York
-$1.03K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$731
3
UBS Group
UBS Group
Switzerland
-$8
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
1
Clear Street
New York
– -$1.03K -57,762 Closed
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
– -$731 -45,830 Closed
UBS Group
3
UBS Group
Switzerland
– -$8 -424 Closed

NLSPW Hedge Fund Activity: Q4 2025 in Review

0 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in NLS Pharmaceutics Warrant (NLSPW) for Q4 2025, worth a combined $0 — down 100% from $1.77K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of NLSPW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Clear Street, exiting entirely with an estimated $1.03K sold.

  • 0 institutional investors held NLS Pharmaceutics Warrant (NLSPW) as of Q4 2025, down from 3 in Q3 2025.
  • Funds reported $0 of NLS Pharmaceutics Warrant stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new NLS Pharmaceutics Warrant positions in Q4 2025 and 3 closed out, a net change of -3 holders.
  • The largest NLS Pharmaceutics Warrant seller in Q4 2025 was Clear Street, an estimated $1.03K sold.

Based on aggregated 13F filings for Q4 2025.